Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncolytic Virus Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncolytic Virus Immunotherapymarket, defines the market attractiveness level of Oncolytic Virus Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncolytic Virus Immunotherapy industry, describes the types of Oncolytic Virus Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncolytic Virus Immunotherapy market and the development prospects and opportunities of Oncolytic Virus Immunotherapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncolytic Virus Immunotherapy market in Chapter 13.
By Player:
Merck
Shanghai Sunway Biotech
Amgen
Sorrento Therapeutics
Oncorus
TILT Biotherapeutics
By Type:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
By End-User:
Hospitals
Clinics
Ambulatory Surgical Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncolytic Virus Immunotherapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncolytic Virus Immunotherapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncolytic Virus Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncolytic Virus Immunotherapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncolytic Virus Immunotherapy Market Analysis and Outlook to 2022
-
7.1 Global Oncolytic Virus Immunotherapy Consumption (2017-2022)
-
7.2 United States Oncolytic Virus Immunotherapy Consumption (2017-2022)
-
7.3 Europe Oncolytic Virus Immunotherapy Consumption (2017-2022)
-
7.4 China Oncolytic Virus Immunotherapy Consumption (2017-2022)
-
7.5 Japan Oncolytic Virus Immunotherapy Consumption (2017-2022)
-
7.6 India Oncolytic Virus Immunotherapy Consumption (2017-2022)
-
7.7 South Korea Oncolytic Virus Immunotherapy Consumption (2017-2022)
8 Region and Country-wise Oncolytic Virus Immunotherapy Market Analysis and Outlook to 2028
-
8.1 Global Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
-
8.2 United States Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
-
8.3 Europe Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
-
8.4 China Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
-
8.5 Japan Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
-
8.6 India Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
-
8.7 South Korea Oncolytic Virus Immunotherapy Consumption Forecast (2022-2028)
9 Global Oncolytic Virus Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Engineering Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Wild-Type Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
10 Global Oncolytic Virus Immunotherapy Market Outlook by Types and Applications to 2028
-
10.1 Global Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Engineering Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Wild-Type Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncolytic Virus Immunotherapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncolytic Virus Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncolytic Virus Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncolytic Virus Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncolytic Virus Immunotherapy Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Oncolytic Virus Immunotherapy Product and Service
-
14.2 Shanghai Sunway Biotech
-
14.2.1 Shanghai Sunway Biotech Company Details
-
14.2.2 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product and Service
-
14.3 Amgen
-
14.3.1 Amgen Company Details
-
14.3.2 Amgen Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Oncolytic Virus Immunotherapy Product and Service
-
14.4 Sorrento Therapeutics
-
14.4.1 Sorrento Therapeutics Company Details
-
14.4.2 Sorrento Therapeutics Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Product and Service
-
14.5 Oncorus
-
14.5.1 Oncorus Company Details
-
14.5.2 Oncorus Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Oncorus Oncolytic Virus Immunotherapy Product and Service
-
14.6 TILT Biotherapeutics
-
14.6.1 TILT Biotherapeutics Company Details
-
14.6.2 TILT Biotherapeutics Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncolytic Virus Immunotherapy
-
Figure Oncolytic Virus Immunotherapy Picture
-
Table Global Oncolytic Virus Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncolytic Virus Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncolytic Virus Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncolytic Virus Immunotherapy Consumption by Country (2017-2022)
-
Figure United States Oncolytic Virus Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe Oncolytic Virus Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure China Oncolytic Virus Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncolytic Virus Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India Oncolytic Virus Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncolytic Virus Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Oncolytic Virus Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncolytic Virus Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Engineering Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Wild-Type Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Engineering Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wild-Type Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncolytic Virus Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncolytic Virus Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Oncolytic Virus Immunotherapy Product and Service
-
Table Shanghai Sunway Biotech (Foundation Year, Company Profile and etc.)
-
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Oncolytic Virus Immunotherapy Product and Service
-
Table Sorrento Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Product and Service
-
Table Oncorus (Foundation Year, Company Profile and etc.)
-
Table Oncorus Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncorus Oncolytic Virus Immunotherapy Product and Service
-
Table TILT Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Product and Service
-
